2015
Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator
Kron J, Sauer W, Mueller G, Schuller J, Bogun F, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA, Crawford T. Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator. Journal Of Interventional Cardiac Electrophysiology 2015, 43: 55-64. PMID: 25676929, DOI: 10.1007/s10840-015-9978-3.Peer-Reviewed Original ResearchConceptsCardiac magnetic resonanceImplantable cardiac defibrillatorPositron emission tomographyAppropriate ICD therapyAnti-tachycardia pacingICD therapyCardiac defibrillatorLeft ventricular ejection fractionAppropriate ICD interventionsSecondary prevention indicationTrue natural historyOutcomes of patientsMulticenter retrospective reviewVentricular ejection fractionEnhanced cardiac CTExtracardiac sarcoidosisICD interventionsCardiac sarcoidosisPrevention indicationConsecutive patientsEjection fractionHeart transplantRetrospective reviewSarcoidosis patientsVentricular arrhythmias
2008
Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience
LUEBBERT JJ, LEE FA, ROSENFELD LE. Pacemaker Therapy for Early and Late Sinus Node Dysfunction in Orthotopic Heart Transplant Recipients: A Single‐Center Experience. Pacing And Clinical Electrophysiology 2008, 31: 1108-1112. PMID: 18834460, DOI: 10.1111/j.1540-8159.2008.01149.x.Peer-Reviewed Original ResearchConceptsOrthotopic heart transplantationSinus node dysfunctionOHT recipientsEarly complicationsTransplant recipientsLate sinus node dysfunctionSignificant sinus node dysfunctionOrthotopic heart transplant recipientsHeart transplant clinicMean age 50.2Heart transplant recipientsSingle-center experienceAge 50.2Electrophysiology serviceTransplant clinicHeart transplantationHeart transplantPermanent pacemakerLikely multifactorialPacemaker therapyLarge cohortPatientsAmbulatory monitoringRecipientsPacemaker
2004
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation
Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL, Investigators A. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation. Journal Of The American College Of Cardiology 2004, 43: 1201-1208. PMID: 15063430, DOI: 10.1016/j.jacc.2003.11.032.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCatheter AblationDigoxinDrug Therapy, CombinationElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedMultivariate AnalysisPacemaker, ArtificialStroke VolumeTreatment OutcomeConceptsCalcium channel blockersAtrial Fibrillation FollowAtrial fibrillationChannel blockersAFFIRM studyDrug classesFirst drugAdequate rate controlFirst drug classFrequent medication changesRhythm Management (AFFIRM) studyMajority of patientsBeta-adrenergic blockersRate control drugsElectrocardiographic resultsMedication changesWalk testInitial treatmentClinical variablesEfficacy criteriaDrug combinationsHeart rateEffective drugsPatientsMultivariate analysis
1995
Thromboembolic complications after Fontan operations.
Rosenthal D, Friedman A, Kleinman C, Kopf G, Rosenfeld L, Hellenbrand W. Thromboembolic complications after Fontan operations. Circulation 1995, 92: ii287-93. PMID: 7586425, DOI: 10.1161/01.cir.92.9.287.Peer-Reviewed Original ResearchConceptsRate of thrombosisFontan operationThromboembolic complicationsTotal cavopulmonary connectionThromboembolic eventsCavopulmonary connectionTime of presentationConduit interpositionCerebrovascular eventsFontan procedurePerioperative periodSignificant morbidityAtriopulmonary connectionVenous circulationComplicationsLeft ventriclePatientsThrombosisOverall rateYearsThromboembolismMorbiditySurgeryThrombusGroup